ATE251751T1 - Verfahren zur beurteilung der genotoxizität einer verbindung - Google Patents

Verfahren zur beurteilung der genotoxizität einer verbindung

Info

Publication number
ATE251751T1
ATE251751T1 AT00981433T AT00981433T ATE251751T1 AT E251751 T1 ATE251751 T1 AT E251751T1 AT 00981433 T AT00981433 T AT 00981433T AT 00981433 T AT00981433 T AT 00981433T AT E251751 T1 ATE251751 T1 AT E251751T1
Authority
AT
Austria
Prior art keywords
compound
genotoxicity
assessing
cell
observing
Prior art date
Application number
AT00981433T
Other languages
English (en)
Inventor
Marc Pallardy
Daniel Marzin
Sophie Meintieres
Armelle Biola
Original Assignee
Inst Nat Sante Rech Med
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Pasteur Institut filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE251751T1 publication Critical patent/ATE251751T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
AT00981433T 1999-11-19 2000-11-17 Verfahren zur beurteilung der genotoxizität einer verbindung ATE251751T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914603A FR2801320B1 (fr) 1999-11-19 1999-11-19 Procede d'evaluation de la genotoxicite d'un compose
PCT/FR2000/003206 WO2001036970A1 (fr) 1999-11-19 2000-11-17 Procede d'evaluation de la genotoxicite d'un compose

Publications (1)

Publication Number Publication Date
ATE251751T1 true ATE251751T1 (de) 2003-10-15

Family

ID=9552331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981433T ATE251751T1 (de) 1999-11-19 2000-11-17 Verfahren zur beurteilung der genotoxizität einer verbindung

Country Status (8)

Country Link
US (1) US6713261B1 (de)
EP (1) EP1230546B1 (de)
JP (1) JP2003514540A (de)
AT (1) ATE251751T1 (de)
CA (1) CA2391998A1 (de)
DE (1) DE60005854T2 (de)
FR (1) FR2801320B1 (de)
WO (1) WO2001036970A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315889T3 (es) * 2004-07-14 2009-04-01 Janssen Pharmaceutica Nv Ensayo de deteccion de p75ntr para identificar moduladores de la apoptosis.
EP2199794A1 (de) 2008-12-17 2010-06-23 Universiteit Maastricht Verfahren zur Identifizierung von krebserregenden Verbindungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229265A (en) * 1990-03-13 1993-07-20 Litron Laboratories Process for analyzing clastogenic agents

Also Published As

Publication number Publication date
EP1230546A1 (de) 2002-08-14
EP1230546B1 (de) 2003-10-08
DE60005854D1 (de) 2003-11-13
DE60005854T2 (de) 2004-08-19
FR2801320A1 (fr) 2001-05-25
CA2391998A1 (fr) 2001-05-25
FR2801320B1 (fr) 2002-02-15
WO2001036970A1 (fr) 2001-05-25
US6713261B1 (en) 2004-03-30
JP2003514540A (ja) 2003-04-22

Similar Documents

Publication Publication Date Title
DE59908887D1 (de) Verfahren zur ein- bzw. abschaltung von verbrauchern
DE59907655D1 (de) Schnellverschluss für ein endoskop
DE69939274D1 (de) Stents für blutgefässe
DE69838689D1 (de) Verfahren zur Aktualisierung von Konten
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
ATE353916T1 (de) Chimärische natriuretische peptide
DE60033236D1 (de) System zur vermeidung von heckcrashs bei flugzeugen
DE60138034D1 (de) Verteilte dienstearchitektur für eine verkaufs- oder dienstleistungsstelle
WO1999025843A3 (en) Human checkpoint kinase, hcds1, compositions and methods
EP1262556A3 (de) Antimikrobielle Peptide und Verfahren zu ihrer Identifizierung und Verwendung
DE69923226D1 (de) Beschleunigungsaufnehmer für autoreifen
DE50102671D1 (de) Diethyloctandioldicarbamate und diethyloctandioldiallophanate, verfahren zu ihrer herstellung und ihre verwendung
DK0968314T3 (da) Cobaltbaseret legering, artikel fremstillet af legeringen samt fremgangsmåde til fremstilling deraf
ATE251751T1 (de) Verfahren zur beurteilung der genotoxizität einer verbindung
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
DE69811677D1 (de) Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.
DE50106321D1 (de) Verfahren zur bereitstellung von ortsinformation
FI920562A0 (fi) Saett att foerbaettra ljudisolerings- foermaogan hos haolbjaelklag samt en bjaelklagskombination med god ljudisoleringsfoermaoga.
DE60114567D1 (de) Selektive acylierung von a82846-glycopeptid-analoge
ITPR970039A0 (it) Lega per rivestimenti o riporti resistenti alla corrosione.
DE60123067D1 (de) Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut
WO2002026954A3 (en) Truncated phosphodiesterase-7 polypeptides
DE69738945D1 (de) Rken
DE50214530D1 (de) Verfahren für den Brieftaubensport
DE69719726D1 (de) Verfahren zur Detektion von Leukämie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties